JonesTrading Initiates Coverage On Durect with Buy Rating, Announces Price Target of $37
JonesTrading analyst Sean Kim initiates coverage on Durect (NASDAQ:DRRX) with a Buy rating and announces Price Target of $37.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Catalent (NYSE:CTLT) shares increased by 27.6% to $71.5 during Monday’s pre-market session. The market value of their…
5 Most Expensive Health Care Stocks You Should Worry About
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
Reported Late Monday, DURECT Corp. Announces 1-For-10 Reverse Stock Split
URECT Corporation (NASDAQ:DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT's board of
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Gainers
Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.